The market researcher attributes potential growth to novel production technologies that are enabling the addition of omega-3s to an expanding range of food and beverages.
The U.S. omega-3 fatty acid ingredient market will grow 40% between 2010 and 2015, to reach $7 billion, according to Packaged Facts’ new “Omega-3 Foods and Beverages in the U.S., 3rd Edition” report. The market researcher attributes potential growth to novel production technologies that are enabling the addition of omega-3s to an expanding range of food and beverages, without causing unpleasant fishy odor or taste.
“Omega-3 oils are in demand, and the attention is helping to fuel growth in the still-maturing industry,” says Packaged Facts.
In 2010, U.S. retail sales of food and beverage products touting “high omega-3” or “high DHA [docosahexaenoic acid]” claims grew 11%, approaching $4 billion.
“When the first omega-3-enriched foods entered the market in 2003, some predicted that there would be a flood of products within a couple of years. But the challenges of finding ways to get the fatty acids into foods and beverages, making the resulting product palatable and achieving a reasonable shelf life, were more daunting than expected,” said Don Montuori, publisher of Packaged Facts. “Now that many of these technology hurdles have been overcome, more categories of products have become viable candidates for fortification with omega fatty acids.”
“Several industry experts we interviewed believe that the biggest trend in the next five to ten years will be food and beverage companies seeking to fortify their products with omegas,” he added.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.